» Articles » PMID: 7591738

Possible Identification of Cervicogenic Headache Among Patients with Migraine: an Analysis of 374 Headaches

Overview
Journal Headache
Publisher Wiley
Specialties Neurology
Psychiatry
Date 1995 Sep 1
PMID 7591738
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

According to Sjaastad, the pain in cervicogenic headache, a form not recognized by the IHS, is long lasting and always side-locked unilateral. The frequency of side-locked unilateral pain (defined here as no change in side from onset) and other characteristics of cervicogenic headache were investigated in 300 outpatients using information collected on standard forms in structured interviews. Three hundred seventy-four headaches diagnosed according to IHS criteria were identified. Three hundred forty-eight of these headaches were long-lasting (duration of more than 4 hours); migraine (65%) followed by tension-type headache (25%) were the commonest forms. Side-locked unilaterality was present in 29% (101 of 348), and occurred most frequently in migrainous disorders not fulfilling the criteria (25 of 56, 44.6%). This group differed significantly from the other migraine conditions for longer pain duration (P < 0.02) and less frequent nausea, vomiting, photophobia, phonophobia (P < 0.0001), and aggravation by physical activity (P < 0.02). With these characteristics, this group resembled cervicogenic headache. However, in none of these patients was pain triggered by head or neck movements, and the frequency of head or neck trauma did not differ from other headaches. A more precise definition of clinical criteria for cervicogenic headache vs migraine is, therefore, required.

Citing Articles

Diagnostic Value of Single-Photon Emission Computed Tomography/Computed Tomography Scans with Tc-99m HDP in Cervicogenic Headache.

Cho P, Kim T, Ji G, Park S, Yun M, Shin D J Clin Med. 2020; 9(2).

PMID: 32024217 PMC: 7074323. DOI: 10.3390/jcm9020399.


The efficacy of botulinum toxin in patients with cervicogenic headache: a placebo-controlled clinical trial.

Karadas O, Ozturk B, Ulas U, Kutukcu Y, Odabasi Z Balkan Med J. 2014; 29(2):184-7.

PMID: 25206992 PMC: 4115864. DOI: 10.5152/balkanmedj.2012.003.


The physical examination of migraine.

Sorrell M Curr Pain Headache Rep. 2006; 10(5):350-4.

PMID: 16945251 DOI: 10.1007/s11916-006-0059-2.


Do the proposed cervicogenic headache diagnostic criteria demonstrate specificity in terms of separating cervicogenic headache from migraine?.

Fishbain D, Lewis J, Cole B, Cutler R, Steele Rosomoff R, Rosomoff H Curr Pain Headache Rep. 2003; 7(5):387-94.

PMID: 12946293 DOI: 10.1007/s11916-003-0039-8.


Cervicogenic headache: anatomic basis and pathophysiologic mechanisms.

Bogduk N Curr Pain Headache Rep. 2001; 5(4):382-6.

PMID: 11403743 DOI: 10.1007/s11916-001-0029-7.